News
The firmware update adds energy tracking, sensor support, and improved readings. Users get these features without changing ...
Monotherapy efficacy and safety profile provided backbone for clinical development strategy in 1L combination with nivolumab ...
The German Neuroscience Center, one of the UAE’s leading psychology, psychiatry, and neurology clinics, has introduced two ...
Bonilla, MD, MSEd, discusses 5-year data from the phase 3 CheckMate 577 trial, presented at the 2025 ASCO Annual Meeting.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hund ...
Marlou Janssen, Board Member at Field Medical, Sonion, Acarix, EBAMed, and Inspiration Healthcare - Experienced executive and ...
A brief illustration of the main cellular processes and biological pathways that contribute to the development of Pancreatic ...
Risk has changed. E-waste is not just waste, it is a compliance failure waiting to happen, a data breach in transit, a ...
Alzheimers Concept Horizontal] travellinglight/iStock via Shares of INmune Bio (NASDAQ:INMB [ dropped on Monday after the company did not achieve the main goal in a mid-stage trial for its TNF ...
2d
Fintel on MSNBTIG Downgrades INmune Bio (INMB)Fintel reports that on July 1, 2025, BTIG downgraded their outlook for INmune Bio (NasdaqCM:INMB) from Buy to Neutral.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results